Liberty BioSecurity is a privately-owned life sciences company specializing in the development of breakthrough clinical stage pharmaceuticals and biological-based capabilities for industry and government.
Global Leadership Made up of globally recognized scientists, physicians, and industry experts, the Liberty team and its collaborators are developing advanced methods that uncover the answers to countering biological threats before they have been discovered.
Edward Schulak | Co-founder, Chairman
Jason Anderson | Co-founder, Chief Executive Officer
Mike Harris | Chief Strategy Officer
Sean Riley | Chief Business Officer
Dr. Mark Boguski | Chief Medical Officer
Dr. Jose Morey | Chief Medical Innovation Officer
Kyle Landry | Chief Scientist, Expeditionary Science and Special Programs
Matthew Easterday | Chief General Counsel
David Sinclair | Co-Founder, Chief Scientific Advisor
Ari Patrinos | Board Member
Carlos Bustamante | Board Member
Lon Augustenborg | Board Member
James Cole | Board Member
Rajendra Apte | Board Member
Liberty's network of public and private institutions are a source of scientific breakthroughs.